智通财经网·2025-09-12 23:10Group 1 - Pfizer (PFE.US) and Moderna (MRNA.US) stocks fell sharply following reports that Trump administration health officials plan to present claims linking COVID-19 vaccines to 25 child deaths to a key vaccine advisory committee next week [1][2] - The Advisory Committee on Immunization Practices (ACIP) is responsible for reviewing vaccination data and making recommendations that significantly influence vaccine policy [1][2] - Following the news, Pfizer's stock dropped by 3.98%, Moderna's stock fell by 7.4%, and Novavax (NVAX.US) also saw a decline of 3.62% [1] Group 2 - The U.S. Department of Health and Human Services (HHS) stated that the FDA and CDC regularly analyze vaccine safety data and share results through established ACIP processes, emphasizing that any unverified claims should be considered speculation [1][2] - Moderna highlighted that the safety of its vaccine is being closely monitored by the company, FDA, and regulatory agencies in over 90 countries, with no new safety concerns reported in systems monitoring across various regions [2] - Research indicates that mRNA vaccines produced by Pfizer and Moderna are safe and effective, with severe adverse reactions being extremely rare, although there is a slight increase in myocarditis risk among young males [2][3] Group 3 - FDA Director Marty Makary acknowledged that there have been self-reported cases of child deaths following COVID-19 vaccination, but did not provide specific data, stating that a report will be released in the coming weeks [3] - The claims made by the Trump administration appear to be based on data from the Vaccine Adverse Event Reporting System (VAERS), which collects self-reported data that requires thorough investigation to determine causality [2]